Key result
Saudi Arabian CV research consists of ~58% low-level evidence with no improvement trend over time.
Why the study?
Despite increased investment in cardiovascular disease research in Saudi Arabia, the strength and level of evidence derived from these research activities remained unclear.
Population
418 published clinical Cardiovascular Medicine articles including a population from Saudi Arabia
Design
Systematic review
Authors
Loading...
Warrants caution applying Saudi cardiovascular findings clinically; confirms stagnant low evidence levels over three decades.
Systematic Review (n=418)
Effect estimate: β -0.07 (95% CI -0.20, -0.06)
p-value: p=0.236
The level of evidence in clinical cardiovascular medicine research in Saudi Arabia is predominantly low (Level IV), with no significant improvement over the past three decades.
Alotaibi et al. (2021) conducted a systematic review in Cardiovascular disease (n=418). Clinical cardiovascular medicine research in Saudi Arabia predominantly consists of low-level evidence (57.8% level IV studies), with no significant trend toward higher evidence levels over time.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: